PARIS — Russia’s Sputnik V vaccine is 91.6 percent effective against symptomatic Covid-19, according to results published Tuesday that independent experts said allayed transparency concerns over the jab, which Moscow is already rolling out.
Sputnik V — named after the Soviet-era satellite — was approved in Russia months before results from its final-stage clinical trials were published, leading to skepticism among experts.
But the new analysis of data from 20,000 Phase 3 trial participants, published in the medical journal The Lancet, suggests that the two-dose vaccination offers more than 90 percent efficacy against symptomatic Covid-19.
“The development of the…
Keep on reading: Lancet study: Russia’s Sputnik V vaccine 91.6% effective